India
# |
Name |
Goodwill |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 295.40 M
|
March 31, 2024 | USD 11.23 | 1.68% |
|
India |
|
2 |
USD 65.72 M
|
March 31, 2024 | USD 32.88 | -0.93% |
|
India |
|
3 |
USD 54.51 M
|
March 31, 2024 | USD 20.71 | -0.50% |
|
India |
|
4 |
USD 39.92 M
|
March 31, 2024 | USD 6.91 | -0.24% |
|
India |
|
5 |
USD 12.47 M
|
March 31, 2024 | USD 9.20 | 2.64% |
|
India |
|
6 |
USD 8.08 M
|
March 31, 2024 | USD 16.75 | 0.23% |
|
India |
|
7 |
USD 668.99 K
|
March 31, 2024 | USD 9.86 | 2.71% |
|
India |
|
8 |
USD 0.00
|
March 31, 2024 | USD 8.61 | -1.79% |
|
India |
|
9 |
USD 0.00
|
March 31, 2024 | USD 0.14 | 3.84% |
|
India |
|
10 |
USD 0.00
|
March 31, 2024 | USD 1.48 | 10.54% |
|
India |
|
11 |
USD 0.00
|
March 31, 2024 | USD 0.59 | -0.38% |
|
India |
|
12 |
USD 0.00
|
March 31, 2024 | USD 1.29 | 2.70% |
|
India |
|
13 |
USD 0.00
|
March 31, 2024 | USD 1.84 | 1.24% |
|
India |
The Clinical Trials company in India with the highest Goodwill is Jubilant Pharmova Limited (NSE: JUBLPHARMA.NS) at USD 295.40 M.
The Clinical Trials company in India with the lowest Goodwill is Sun Pharma Advanced Research Company Limited (NSE: SPARC.NS) at USD 0.00.
The top 10 Clinical Trials companies in India by Goodwill are Jubilant Pharmova Limited, Dr. Lal PathLabs Limited, Metropolis Healthcare Limited, Indegene Limited, Thyrocare Technologies Limited, Glenmark Pharmaceuticals Limited, Vimta Labs Limited, Syngene International Limited, TAKE Solutions Limited and Suven Life Sciences Limited.
The bottom 10 Clinical Trials companies in India by Goodwill are Sun Pharma Advanced Research Company Limited, Ind-Swift Laboratories Limited, Vineet Laboratories Limited, Suven Life Sciences Limited, TAKE Solutions Limited, Syngene International Limited, Vimta Labs Limited, Glenmark Pharmaceuticals Limited, Thyrocare Technologies Limited and Indegene Limited.